Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
0.010 Biomarker disease BEFREE Regarding these results, it might be concluded that Bcl6 knockdown combined with PMA therapy could present a new therapeutical strategy for refractory CML patients to imatinib. 28589317 2017